MUFG Americas’s AngioDynamics ANGO Stock Holding History

MUFG Americas’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-91	Closed	-$1K	–	1119
2017 Q2	$1K	Hold	91	–	–	﹤0.01%	1100
2017 Q1	$2K	Hold	91	–	–	﹤0.01%	1029
2016 Q4	$2K	Buy	+91	New	+$1.52K	﹤0.01%	1005

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

MUFG Americas's ANGO Position: Q3 2017 in Review

MUFG Americas sold out of AngioDynamics (ANGO) in Q3 2017, closing a stake of 91 shares — an estimated $1K sold.

MUFG Americas first reported a position in ANGO in Q4 2016 and held it in 3 quarters. The position peaked at $2K in Q1 2017. 168 funds tracked by Wall St. Rank hold ANGO as of Q3 2017.

MUFG Americas reported no remaining AngioDynamics position as of Q3 2017 after selling out during the quarter.
MUFG Americas sold 91 AngioDynamics shares in Q3 2017, an estimated $1K.
MUFG Americas first reported a position in AngioDynamics in Q4 2016 and held it in 3 quarters.
MUFG Americas's AngioDynamics position peaked at $2K in Q1 2017.
168 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2017.

Based on MUFG Americas's 13F filing for Q3 2017, filed 13 Nov 2017.